The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
The technical storage or access that is used exclusively for statistical purposes.
The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Project ALIVE: Montana CIL Trainings
Project ALIVE (Accessible Life-saving Integrated Vaccine Equity) is a short-term focused effort to remove barriers to COVID-19 vaccinations for people with disabilities living in the rural areas of Montana, Arkansas, and Missouri. Rooted in the values of self-determination and self direction, the project does not seek to persuade or convince, but will serve as a resource for those who want the vaccine and those seeking further information in order to make an informed decision.
Training 1: Making the Vaccine Process Accessible: Understanding Legal Rights and Reducing Trauma in Montana
Training 2: Navigating Vaccine Hesitancy for Montana Centers for Independent Living
Making the Vaccine Process Accessible: Understanding Legal Rights and Reducing Trauma in Montana
By the end of the training, you will be familiar with:
Presenter: Melissa Marshall, JD
Navigating Vaccine Hesitancy for Montana Centers for Independent Living
By the end of this presentation, you will be able to:
Presenter: Regina S. Dyton (she/her)
Project ALIVE was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $1,900,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.